Quantcast

The MedZilla.com Employment Report for September, 2013: New Bio-Tech Advancements Mean More Jobs in Related Fields

September 12, 2013

MedZilla.com reports: Labor productivity increased at a rate of 2.3% this quarter; while the unemployment rate continued its downward trend, falling to a low of 7.3% last month. 169,000 jobs were added to the nation’s payrolls in August according to Friday's report from the Bureau’s latest situation report, showing the jobless rate down from 8.1% this time last year. (bls.gov, 9/6/2013)

Seattle, WA (PRWEB) September 12, 2013

According to the global outplacement firm Challenger, Grey & Christmas report for August, GDP grew at a better-than-expected 2.5% annual rate in the second quarter. While manufacturing activity has been on the rise, the economy is in a much better position to weather these storms than it was just a year or two ago. Challenger also noted that the mortgage industry seemed to be picking up steam as well, which would be good news for a number of supporting job and financial markets. (challengergray.com, 9/5/2013)

"When the economy is doing well, that is good news for everyone. People love investing in the future when the future looks bright. In this case, we've had a great year of people being able to go back to work across a variety of sectors, creating a strong economic base. Now we're even seeing the housing market peek its head out from the shadows. There are some very exciting developments happening and people want their companies to be a part of that. So, get your resumes out there," encourages Del Johnston, Manager of Client Relations at MedZilla.com.

The driving force behind new job opportunities in Biotechnology, Pharmaceutical Research, and Healthcare technology have been the incredible research advances which are being made and built upon across the country at an ever increasing pace. For example, research scientists at Emory University, collaborating with their colleges at Georgia Tech recently created a process for distinguishing cardiac muscle cells from stem cell cultures using molecular florescent markers.

There are many applications for being able to "tag" specific types of cells. Being able to identify pure cardiac muscle cells is vital when attempting to avoid tumor formation after cells have been transplanted. Until now, this has been technically challenging; however, with this molecular beacon method could reduce reformation tremendously.

The molecular beacons themselves are small devices which only become fluorescent when they attach to cells which have particular. Here, they are targeting a specific protein found in the muscle cells of the heart.

This technique is expected to have many far reaching applications in regenerative medicine, as well. Damaged heart muscle cells from cardiac failure or heart attack could be could be healed using purified transplanted cardiac muscle cells.

Other applications are expected because of the beacon method's ability to be applied to other types of cells produced from stem cell cultures. One of the researchers on the project, co-senior author Young-sup Yoon, MD, PhD, professor of medicine (cardiology) and director of stem cell biology at Emory University School of Medicine, weighs in on the possibilities:

"Often, we want to generate a particular cell population from stem cells for introduction into patients, but the desired cells often lack a readily accessible surface marker, or that marker is not specific enough, as is the case for cardiac muscle cells. This technique could allow us to purify almost any type of cell."

They believe the next big step for developing these purified cells for therapeutic use toward cardiac diseases will be finding a method for developing them into artificial tissues. (sciencedaily.com, 9/5/2013)

"There are many more stories of incredible advances like this one being made in research and science tech, which is a great jobs boon for scientists and all of their supporting staff. It's an exciting time and the job numbers are most definitely reflecting that. I expect that we will continue to see this in the next quarter as we did in the last," says John Burkhardt Managing Director of MedZilla.com.

Medzilla.com is one of the most notable and essential resources for accessing and finding healthcare, pharmaceutical, and bio-tech employment information on the internet. Their employment experts connect real qualified and skilled workers with top industry employers.

**********************************************************************************************************

About MedZilla.com:

Established in mid-1994, MedZilla is the original and leading web site to serve career and hiring needs for professionals and employers in biotechnology, pharmaceuticals, medicine, science and healthcare. The MedZilla jobs database contains about 7,500 open positions. The resume database currently contains over 295,000 resumes with 26,500 less than three months old. These resources have been characterized as the largest, most comprehensive databases of their kind on the web in the industries served.

MedZilla(R) is a Registered Trademark owned by MedZilla Inc. Copyright (C)MedZilla, Inc. Permission is granted to reproduce and distribute this text in its entirety, and if electronically, with a link to the URL http://www.medzilla.com. For permission to quote from or reproduce any portion of this message, please contact MedZilla, Inc. at press(at)medzilla(dot)com

Press Inquiries

Contact: MedZilla, Inc.

Phone: (360) 657-5681

press(at)medzilla(dot)com

###

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11113688.htm


Source: prweb



comments powered by Disqus